VSTM1-v2 does not drive human Th17 cell differentiation: A replication study

PLoS One. 2023 Apr 13;18(4):e0284404. doi: 10.1371/journal.pone.0284404. eCollection 2023.

Abstract

Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor expressed on human myeloid cells. We previously showed that dendritic cell (DC)-driven Th17 cell differentiation of human naive CD4+ T cells requires presence of neutrophils, which is inhibited by SIRL-1 ligation. VSTM1-v2 is a soluble isoform of SIRL-1, which was previously proposed to function as a Th17 polarizing cytokine. Here, we investigated the effect of VSTM1-v2 on DC-driven Th17 cell development. Neutrophils induced DC-driven Th17 cell differentiation, which was not enhanced by VSTM1-v2. Similarly, we found no effect of VSTM1-v2 on cytokine-driven Th17 cell development. Thus, our results do not support a role for VSTM1-v2 in Th17 cell differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cytokines*
  • Dendritic Cells
  • Humans
  • Neutrophils
  • Protein Isoforms
  • Th17 Cells*

Substances

  • Cytokines
  • Protein Isoforms
  • VSTM1 protein, human

Grants and funding

This work was supported by Amsterdam UMC, University of Amsterdam, and by a Vici grant from the Netherlands Organization for Scientific Research (NWO, grant no. 91815608, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.